Please login to the form below

Not currently logged in
Email:
Password:

F-star appoints vice president of protein sciences

Mike Davies joins from CPI Biologics

F-star Mike DaviesVienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site.

Davies has over 15 years of experience the development, manufacture and commercialisation of recombinant protein therapeutics and joins F-star from CPI Biologics where he has served as head of analytical strategy, biologics since April 2014.

Prior to this, Davies worked at Swiss pharma supplier Lonza, which he joined as a scientist in 1997 and held several senior leadership roles in analytical strategy and development before being promoted to analytical services head in 2009.

John Haurum, chief executive officer of F-star, said: “We are pleased to welcome Mike to the team and look forward to working with him.

“His strong experience in the development and commercialisation of recombinant protein therapeutics will further enable us to progress our immune-oncology pipeline into the clinic.”

23rd March 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics